The lpr locus was defined by an autosomai recessive mutation initially observed in strain MRL (1). Whereas nonmutant mice of this strain develop late-onset autoimmune disease characterized by chronic glomerulonephritis, MRL-lpr/lpr mice experience severe ear!y-onset subacute glomerulonephritis, arteritis, and arthritis associated with massive lymphadenopathy and splenomegaly (1-3). The lymph nodes and spleens of lpr homozygotes are expanded by an abnormal population of cells that coexpress cell surface determinants usually restricted to T cells (Thy-1, Ly-1) or B cells [Ly-5(B220)] (4-9), and are deficient in their ability to produce interleukin 2 (IL-2) 1 (9-12). These aberrant cells were clearly shown not to be B cells, in that they had no rearrangements of Ig heavy chain genes (6). MRL-lpr/+ resemble MRL-+/+ mice in terms of disease patterns, longevity, and phenotypic and functional characteristics of their lymphocytes, indicating that the mutation is fully recessive in this strain.
SJL-lpr/lpr, -lpr/+, and -+/+ mice were compared for longevity, histopathology, expression of murine leukemia viruses (MuLV), and phenotypic characteristics of lymphocytes.
Materials and Methods
Mice. All mice were bred by J. B. Roths and E. D. Murphy or were purchased from the Animal Resource colonies of The Jackson Laboratory, Bar Harbor, ME, except for NFS/N, which was obtained from the colonies of the National Institutes of Health. Mice of different strains bearing the lpr mutation had been through at least seven cycles of cross-intercross matings at the time of study.
Histopathology. Moribund mice were sacrificed and tissues were fixed in Fekete's formal-acetic-ethanol solution. Sections (8 t~m) were stained with hematoxylin and eosin for microscopic examination. Sections of kidney were also stained with PAS/Schiffreagent.
Virus Studies. Infectious center assays for ecotropic, xenotropic, and MCF MuLV were performed with mitomycin-C-treated lymphoid cells, as previously described in detail (14, 15) . Infectious ecotropic MuLV in 2% (wt/vol) extracts of tail biopsies (16) was quantitated by UV-XC tests of SC-1 cells inoculated with 0.2 ml of extract.
Flow Microfluorometry (FMF).
Single-cell suspensions from thymus, spleen, and lymph nodes were prepared and stained for FMF analyses using established procedures (14) . The antibodies used in this study and their specificities for normal hematopoietic cells have previously been described in detail (6, 9, 12, (17) (18) (19) (20) (21) . Antibodies to Thy-1, surface Ig (sIg), Ly-5(B220), ThB, Ly-5, XenCSA (14) , and "8C5" were fluorescein labeled. Antibodies to "H-11", Ly-24 and Mac-1 were sandwiched with affinity-purified, fluorescein-labeled rabbit anti-rat Ig. Antibodies to Ly-1, Ly-17, Ia and Lyb-2 were sandwiched with affinity-purified goat anti-mouse IgG2. Fluorescence profiles were generated on a FACS II (B-D FACS Systems, Sunnyvale, CA) from 3 × 104 viable nucleated cells (as determined by combined gating with propidium iodide to exclude dead cells, and narrow forward-angle light scatter to exclude red cells), using logarithmic amplification of signals from the photomultiplier tubes.
DNA Analyses. High molecular weight DNA was prepared, cleaved with restriction endonucleases, and separated by electrophoresis on 0.6% agarose gels as previously described (22) . After transfer to nitrocellulose membranes, the blots were probed with 32P-labeled pBR322 containing an ecotropic envelope-specific DNA fragment, pEc-B4 (23) using established techniques (22) .
Results

Lymphoproliferation in Mice Homozygous for lpr.
In earlier studies, we found that lpr induced lymphadenopathy in different inbred strains homozygous for the mutation (13) , and that the nodes of these mice were expanded with an abnormal population of Thy-1 +,Ly-1 ÷,Ly-2-or Thy-1-,Ly-1 +,Ly-2-T cells bearing the B cell surface marker, Ly-5(B220) (6) (7) (8) (9) . The effect of lpr on lymphadenopathy in SJL mice homozygous for the mutation was compared at 10 and 26 wk with that in C3H-, MRL-, AKR-, and C56BL/6-1pr/lpr mice ( Fig. 1) . At 10 wk, nodes of SJL-lpr/lpr mice were significantly larger than those of other strains homozygous for lpr. At 26 wk, however, SJL-lpr/lpr nodes were only slightly larger than those of MRL-lpr/lpr mice, and were smaller than those of C3H-lpr/lpr mice.
Lymph node and spleen cells from 4.5-6-mo-old SJL-+/+ and SJL-lpr/lpr mice were tested by FMF for expression of a series of cell surface antigens (Table   I) . As for other strains homozygous for lpr, the predominant phenotype of LN cells from SJL-lpr/lpr mice was Thy-1 +, H-11 +, Ly-5(B220) +, Ly-5 +, Ly-2-, sIg-, ThB-, Ia-(6-9). The reduced frequency of Ly-1 + cells in LN of these mice contrasts with the increased frequency of these cells in the other lpr strains tested (6) . The frequency of Thy-1 + and Ly-5(B220) + cells was also increased in spleen but to a lesser extent than LN, again paralleling studies of other strains homozygous for lpr (6) (7) (8) (9) . The frequency of cells bearing markers not previously examined in lpr mice was also determined. These include Lyb-2 (24), the B cell-specific antigen; Ly-17 (18) , the granulocyte-specific marker; "8C5" (R. L. Coffman, H. C. Morse III, unpublished observations), the myelomonocytic determinant; Mac-1 (19) , and an antigen expressed by the great majority of hematopoietic cells of all lineages, Ly-24 (20, 21) . The frequencies of Lyb-2 + and Ly-17 + cells in both lpr/ lpr and normal tissues corresponded closely to the frequencies of B cells defined by expression of sIg, ThB or Ia ( Table I ), emphasizing that the only B cell determinant greatly altered in expression on lpr cells is Ly-5(B220).
The frequencies of spleen but not LN cells expressing antigens confined to the myelomonocytic lineage (8C5, Mac-l) were increased slightly in lpr mice, corresponding, in part, with reports of increases in macrophages in other strains homozygous for lpr (25, 26) . By comparison, the frequency of cells bearing Ly-24, the major surface glycoprotein of phagocytic cells (20, 21) , and the density of Ly-24 antigens per cell was greatly increased in lpr as compared with normal SJL mice (Table I and Fig. 2 ). In regard to the altered representation of Ly-5(B220) and Ly-24 antigens on SJL-lpr/lpr cells, it should be noted that lpr clearly is not linked to the loci on chromosome 1 or chromosome 2 that, were striking histologic features of lung sections from SJL-lpr/lpr mice (Fig. 4  A) , whereas pulmonary lesions in MRL-lpr/lpr mice were limited to some perivascular and peribronchiolar cuffing without alveolar infiltrates (Fig. 4 B) .
Sections from other tissues of SJL-lpr/lpr mice showed venous congestion and capillary stasis. In view of the marked reduction in the volume of the thoracic cavity occasioned by lymph node hypertrophy, the lung lesions of SJL-lpr/lpr mice probably result in death due to pulmonary insufficiency combined with right-sided heart failure. Comparable histopathologic studies of nine moribund SJL-/pr/+ mice showed that all the animals died with lymphomas, of apparent B cell origin, which resembled the characteristic neoplasms of SJL-+/+ mice (29) . Using a recently defined system that allows comparisons of the histopathology of murine and human lymphomas (30, 31) , the lesions of SJL-lpr/+ mice included follicular center cell lymphomas, immunoblastic lymphomas, and a plasmacytoid lymphoma.
In Vivo and In Vitro Passage of lpr/+ Lymphomas. In earlier studies, (32) (33) (34) it was found that SJL-+/+ lymphomas may be difficult to establish as continuous in vivo or in vitro lines, raising the possibility that the SJL-lpr/+ and -+/+ lesions may not be truly malignant, in spite of their histologic appearances. To evaluate this question, young adult SJL-+/+ mice were inoculated subcutaneously with fragments of lymph nodes from + / + and lpr/+ mice carrying lymphomas. The transplantation studies demonstrated that both + / + and lpr/+ lymphomas could be passaged in + / + recipients. The frequency with which the lymphomas were successfully transplanted was higher for lpr/+ (78%, n = 9) than for + / + lymphomas (59%, n = 27).
Studies of MuLV. Expression of infectious endogenous or exogenous MuLV-
related genomes has been shown to influence the development of B lineage lymphomas (31, 35) . To determine if the effects of lpr on B cell neoplasms in SJL mice could be related to alterations in production of MuLV, tissues from prelymphomatous + / + and lpr/+ mice, as well as lpr/lpr mice were tested for expression of infectious ecotropic, xenotropic, and mink cell focus-inducing (MCF) MuLV. Viruses belonging to the latter two classes of MuLV were not produced by thymocytes, lymph node or spleen cells from any of the animals tested (data not shown), but infectious ecotropic MuLV was produced, to a highly variable extent, by lymphocytes from all three types of mice (Table II) . The data in this table can be summarized as follows: First, a low proportion (<102 out of 107) of cells from thymus, spleen, or lymph nodes from + / + mice produced infectious ecotropic MuLV. Second, >5 × 10 2 OUt o f 10 7 cells from all lymphoid tissues of lpr/lpr mice 3 mo of age or older produced infectious virus of this class. Finally, the virus phenotype of tissues from Ipr/+ mice appeared to differ from that of + / + or lpr/lpr mice. The frequency of virus-positive mice at different ages, and the frequency of virus-producing cells from virus-positive animals tended to be higher in lpr/+ than in + / + mice, but lower than in lpr/ lpr mice. It should be noted that this trend is especially apparent for Ipr/+ mice no more than 4 mo old. In the older age groups (>4 mo), mice with prelymphomatous lesions or overt lymphomas were excluded to avoid the possibility that expression of MuLV might be altered by neoplastic changes. These results We studied the possibility that heightened expression of infectious ecotropic MuLV in SJL-lpr/lpr mice might occur in nonlymphoid as well as lymphoid tissues by testing cell-free extracts from tail biopsies of eight lpr/lpr, four lpr/+, and eight + / + mice 2-4.5 mo old. Extracts from one lpr/lpr and two + / + mice produced low numbers (2-26) of XC cell line plaques under conditions that would yield > 10 s plaques in comparable tests of AKR mouse tissue. These data suggest that expression of infectious ecotropic MuLV is amplified in lymphoid but not in nonlymphoid tissues of SJL-lpr/lpr mice.
Two major questions are raised by these observations. First, is the alteration in MuLV expression detected in SJL-lpr/lpr mice restricted to this strain, or is virus expression also changed in other lpr congenics? This question was examined by testing lymphoid tissues from 3-5-mo-old C57BL/6J, C3H/HeJ, AKR/J, and NZB/BINJ lpr homozygotes and + / + mice for expression of infectious MuLV (Table III) 
. The proportions of thymocytes, spleen cells, and lymph node cells I N D U C E D BY T H E M U T A N T G E N E , lpr
producing ecotropic MuLV were not significantly altered by the lpr mutation in the ecotropic MuLV-positive strains C57BL/6, AKR, or C3H, and neither xenotropic nor MCF MuLV were detected in any of the cultures of cells from these mice. Tests for infectious xenotropic MuLV in ecotropic MuLV-negative NZB mice showed no significant differences between + / + and lpr/lpr for the proportions of virus-producing cells from spleens or lymph nodes. The difference between normal and lpr mice for expression of infectious xenotropic MuLV by thymocytes (Table III) (Table IV) showed that one of two mice inheriting the 6.3 kb pEc-B4-reactive Xba I fragment, two out of five mice inheriting the 11.5 kb fragment, and none of two mice that inherited neither fragment were lpr/+. The results indicated that lpr was not linked to either of the SJL ecotropic MuLV loci.
Discussion The data presented in this report demonstrate a number of important points regarding abnormalities related to the lpr mutation. From information presented here and elsewhere, it is clear that the lpr mutation consistently induces certain abnormalities, regardless of strain background, but that other abnormalities associated with the mutation are highly strain-dependent. Thus, for all strains tested, lpr induces lymphadenopathy and splenomegaly, although there is strainto-strain variation in the extent of proliferation (Fig. 1) (13) . Lymph nodes and spleens of lpr mice from all strains are expanded with cells that coexpress cell surface antigens usually restricted to T cells (Thy-1) or B cells [Ly-5(B220)] (Table I) (6) (7) (8) (9) . These cells are definitely not of B cell origin, as (a) their expansion is limited in neonatally thymectomized mice (37, 38) , and (b) most express Ly-1 in addition to Thy-1 (Table I) (4) (5) (6) (7) (8) (9) . In addition, lpr homozygotes of all strains produce antinuclear antibodies (13 and J. B. Roths, unpublished data).
In contrast, the effects of the lpr mutation on the development of autoimmune disease and expression of MuLV are markedly strain-dependent. MRL-lpr/lpr mice develop accelerated immune-complex glomerulonephritis, arthritis, and vasculitis (1-3, 27, 28), whereas C3H-lpr/lpr and SJL-lpr/lpr mice develop little or no renal, joint, or vascular disease (Fig. 4) (12) . Instead, SJL-lpr/lpr mice developed extensive lymphocytic and inflammatory cell pulmonary infiltrates, and appeared to die with combined pulmonary insufficiency and right-sided heart failure.
Among strains homozygous for lpr and tested for expression of infectious MuLV, the mutation appears to affect only ecotropic MuLV in SJL mice (Tables  II and III (Table IV) . Furthermore, no evidence of additional ecotropic MuLV loci was found.
Our results also indicated that the lpr gene may be expressed to some extent in the heterozygous state on the SJL background, but not on other backgrounds. This view is based most firmly on the observation of a significant difference in survival between SJL-+/+ and -lpr/+ mice (Fig. 3) , and less certainly on enhanced expression of ecotropic MuLV in SJL-lpr/+ mice <4 mo old (Table II) . Similar effects have not been observed with B6, AKR, or MRL lpr heterozygotes. It is noteworthy that the apparent effects of this gene in the heterozygous state only partially resemble its effects in the homozygous state. Thus, although SJL-lpr/+ mice exhibited a shortened life span and enhanced expression of MuLV, they died with lymphomas rather than pulmonary disease, they did not produce antinuclear antibodies (J. B. Roths, unpublished observation), and their spleens and nodes did not contain cells phenotypically characteristic of lpr homozygotes.
The origins and characteristics of the cells responsible for lymphomas of SJL-+ / + mice have been studied since the initial description of these lesions as reticulum cell sarcomas in 1963 (29) . No consensus of opinion has been developed regarding this disease, as some cell lines obtained from old SJL mice were shown to have characteristics of cells in the B lymphocyte lineage (32) (33) (34) , whereas others had characteristics of macrophages or histiocytes (39) . The observation that these neoplasms do not develop in SJL mice rendered deficient of B cells by treatment from birth with anti-IgM (40) (Table II) may also act to accelerate the development of neoplasms. The mechanism of such amplification is unknown, but ecotropic virusinduced generation of some type of recombinant MuLV could be involved. Second, although MCF MuLV have been recovered from nonthymic lymphomas of NFS (15) and SJL-lpr/+ mice (data not shown), these viruses have not been shown to accelerate the development of similar neoplasms in mice inoculated as newborns.
Taken together with data from earlier studies, these results indicate the marked complexities involved in studies of autoimmune disease, even when "single gene models" are studied. The lpr mutation was initially considered as a diseaseinducing alteration of the genome (1, 2), but has subsequently been viewed as a defect accelerating the autoimmune disease of MRL/Mp mice (3, 11, 27) . Other strains homozygous for this mutation develop little or no evidence of autoimmunity, aside from autoantibodies (9, 13, 43) , and die with undetermined causes (9) or, in the case of SJL/J, pulmonary disease (as described herein).
These strain differences may reflect the fact that this single mutation alters the expression of many cellular genes, including those governing expression of cell surface antigens (5-9), protooncogenes (44) , and endogenous MuLV (Table II) . In some cases, expression of these genes is enhanced; in other instances expression is depressed. This variation appears to be, in part, strain-dependent. Although elucidation of these strain-related effects is clearly important, it is unlikely that a fundamental understanding of the abnormalities caused by the lpr mutation will be obtained until the primary defect, probably enzymatic, has been described. In this regard, it has been suggested that the abnormalities induced by lpr and the nonallelic mutation, gld (45) may reflect defects common to a metabolic pathway of importance to T cell differentiation and function (46) . Summary SJL/J mice heterozygous or homozygous for the lpr mutation were compared with SJL/J-+/+ mice for longevity, histopathology, antigenic characteristics of lymphocytes and expression of murine leukemia viruses (MuLV). In comparison to +/+ mice, lpr homozygotes had a markedly shortened life span, died with infiltrative pulmonary disease, but little or no renal disease, and expressed high levels of infectious ecotropic MuLV in lymphoid tissues. SJL-lpr/+ mice had a life span intermediate between SJL-+/+ and dpr/lpr mice, died with lymphomas that histologically resembled the neoplasms of +/+ mice, and sometimes expressed high levels of ecotropic MuLV. The lymphomas of lpr/+ could be transplanted to +/+ recipients in 78% of cases, and continuous in vitro lines were established from some of them. Similar effects on virus expression or lymphoma development were not observed in other strains homozygous or heterozygous for the lpr mutation. These results indicate that the diseases expressed by mice homozygous for the lpr mutation are highly strain-dependent, and that this gene can have an effect in the heterozygous state in SJL mice.
